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Prof. S.Signorelli
The Authors performed an interesting study concerning the risk factors for atherosclerotic diseases in general habitants in Rejkavik (Iceland). Furthermore, the Authors compared findings to data furnished by the Tromso 6 study. The Authors pointed out on similar characteristics of the both north European populations. The study furnishes interesting data on prevalence of such most frequent diseases as the type 2 diabetes and arterial hypertension, and the authors have focused difference among lipid plasma levels occurred in the REFINE population compared to the Tromso population. I agree on the focus on the intima media thickness as useful tool to evaluate the emerging risk condition in individuals (cardiac and/or arterial). However, I want to ask a query alone to be addressed: Authors did not focus on peripheral artery condition as possible marker of extended artery disorders. Please, may the Authors give notice on peripheral artery and/or on ankle brachial index (ABI) measurement. I will be interesting in knowing on it or to ask to explain the reason for this lack?
REVIEWER
Alba Riesgo Director of Hospital Valle del Nalón, Langreo, Asturias, España REVIEW RETURNED 15-Dec-2017
GENERAL COMMENTS
Study on cardiovascular risk factors in northern European populations, traditional and new. This article is based on the comparison of the prevalence results of the different risk factors between two population studies, the REFINE, on the Icelandic population and the TROMSO, on Norwegian population. Methodologically, population sampling is correct in both studies and the prevalence of classic risk factors that are compared to each other. What is not comparable, and therefore, invalidates the paper, is the measure of the carotid plaque, since the definition in each of the works, as well as their way of obtaining, is different. In order for the studies to be compared, the definition and measurement of the atheroma plaque in the carotid should be exactly the same, and they are not. Therefore, the study, at least in comparison of the existence of atheroma plaque in the carotid arteries, is incorrect. The rest of the parameters are compared when they are defined in the same way. One option would be to re-write the article without comparing the measurement of the atheroma plate in the carotids. Or make a descriptive study of the risk factors of the Icelandic population without compared with Norwegian population. In the section of the discussion a description of the results of the study is made, which would correspond to the section of results, but no references are made or compared beyond those of the study itself; It is not discussed, for example, about why such a high percentage of the population is overweight/obese. Perhaps it could be compared to populations in southern Europe where cardiovascular mortality is lower than in the north. The comparison with the prevalence of diabetes mellitus is poor.
As for the emerging factors of cardiovascular risk only talk about the plaque atheroma, has been studied any more? Apolipoprotein A or B, ultrasensitive PCR, homocysteine ... Another discussion that could be raised is what is the best definition of the carotid atheroma plaque as a risk factor, the most accurate or the easiest to obtain primary care and more useful for risk assessment? I consider that as is the article is not acceptable for publication and requires major changes.
VERSION 1 -AUTHOR RESPONSE
Editor Comments to Author: -Please include a colon in the title instead of a full stop, to keep the title one sentence.
Response: in titel -Please complete and include a STROBE checklist, ensuring that all points are included and state the page numbers where each item can be found. The checklist can be downloaded from here: http://www.strobe-statement.org/?id=available-checklists Response: the SREOBE checklist is included.
-The document should be formatted as portrait, and not landscape.
Response: The documents are in portrait format -Please include more detail in the methods sections, rather than including everything in the supplementary files. This makes it easier for the reader to follow the paper. Response: Details on the methods of ultrasound of the carotid artery were included in the paper and moved from the supplementary files.
-Please discuss the limitations of the study in the discussion section.
Response: The limitation of the study is now discussed in the discussion section on page 12
Reviewer: 1 1) The objective is no clearly stated in the Abstract and in the final paragraph of Introduction. Response: This is now clearly stated in the objectives the abstract to reflect the last paragraph in the introduction: "We compare the distribution of cardiovascular risk factors carotids plaque and IMT in two population based studies" in abstract.
2)
The title does not match with the main objective, which is related to the comparison of carotid plaque measured with carotid ultrasound between two populations Response: The title has now been improved to match better with the main objectives. "Population distribution of traditional and the emerging cardiovascular risk factors carotid plaque and IMT: The REFINE-Reykjavik study with comparison to the Tromsø Study" in titel 3)
Which is the rationale to compare carotid ultrasound images between two different populations? Indeed, the authors underscores the difficulties previously described for performing such comparisons. Are the results reliable? Response: Comparison of carotids ultrasound images of plaque between populations is scarse. Inabaa et.al did a meta-analysis on carotid plaque and carotid intima-media thickness for the prediction of coronary heart disease using 27 cohort studies of which only 11 had plaque assessments. (Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Inaba Y, Chen JA, Bergmann SR. Atherosclerosis. 2012 Jan;220(1):128-33. ). The result from this work, among others, shows the importance of carotid plaque as even better predictor of CAD than IMT hence making it extremely important to be able to compare those effects between populations including the role of risk factors. We discuss in the paper the importance of comparison of risk factors between population based cohorts including carotid plaque which is a much studied emerging risk factor. We acknowledge the difficulties in comparison of carotid plaque between studies but believe that the comparison between these well performed cohort studies with rigidly tested protocols is reliable. Reviewer: 2 1)
Authors did not focus on peripheral artery condition as possible marker of extended artery disorders. Please, may the Authors give notice on peripheral artery and/or on ankle brachial index (ABI) measurement.
I will be interesting in knowing on it or to ask to explain the reason for this lack? Response: In the REFINE-Reykjavik study ABI index was calculated but o ABI calculations were done in the Tromsø 6 study hence not in this paper.
Reviewer: 3 1)
This article is based on the comparison of the prevalence results of the different risk factors between two population studies, the REFINE, on the Icelandic population and the TROMSO, on Norwegian population. Methodologically, population sampling is correct in both studies and the prevalence of classic risk factors that are compared to each other. What is not comparable, and therefore, invalidates the paper, is the measure of the carotid plaque, since the definition in each of the works, as well as their way of obtaining, is different. In order for the studies to be compared, the definition and measurement of the atheroma plaque in the carotid should be exactly the same, and they are not. Therefore, the study, at least in comparison of the existence of atheroma plaque in the carotid arteries, is incorrect. The rest of the parameters are compared when they are defined in the same way.
Response: We believe that comparison of carotid plaque assessments between cohorts is possible although we agree that it would be ideal that the methods on how the measurements were performed would be exactly the same. However, we disagree that comparison is of no value as we carried it out which we believe is capturing atherosclerosis with scientific rigor. Furthermore, comparison of carotid plaque between cohorts has been done before comparing different methodology as referred to in response 3, reviewer 1. We emphasise the importance of comparing the effect of risk factors on atherosclerosis between different populations to better understand the development of atherosclerosis.
2)
One option would be to re-write the article without comparing the measurement of the atheroma plate in the carotids. Or make a descriptive study of the risk factors of the Icelandic population without compared with Norwegian population. Response: We disagree with the reviewer that a comparison is of no value as argued above.
3)
In the section of the discussion a description of the results of the study is made, which would correspond to the section of results, but no references are made or compared beyond those of the study itself; It is not discussed, for example, about why such a high percentage of the population is overweight/obese. Response: We agree that more discussion on each of the risk factors reported in the study is warranted not least on overweight/ obesity where prevalence of obesity is globally on increase. For the sake of not letting the report become too long we decided that discussion on each risk factor other than carotid plaque would be somewhat limited. However, we added to the paper a discussion and reference on obesity in Iceland in global and European comparison on page14.
4)
Perhaps it could be compared to populations in southern Europe where cardiovascular mortality is lower than in the north. Response: We agree that comparison with population in southern Europe would be highly interesting but is not within the scope of this paper. The 10-year risk of cardiovascular mortality in Iceland and Norway was similar as in low-risk counties of Europe at the time when the studies were carried out. (Eur J Cardiovasc Prev Rehabil. 2007 Dec; 14(6) :761-8. Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project. Aspelund T1, Thorgeirsson G, Sigurdsson G, Gudnason V.) (Eur J Cardiovasc Prev Rehabil. 2007 Aug; 14(4) :501-7.The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway.Lindman AS1, Veierød MB, Pedersen JI, Tverdal A, Njølstad I, Selmer R.)
5)
The comparison with the prevalence of diabetes mellitus is poor.
Response: In the paper we reviled the age standardized prevalence of type 2 diabetes in the REFINE-Reykjavik study and in Tromsö 6 study in table 1. Also we show the prevalence of type 2 diabetes in the REFINE-study by age and sex in table 2 in supplement 3. Further the prevalence is shown by age and sex from both the REFINE-Reykjavik study and the Tromsö 6 study in picture 1 in supplement 4. We believe our discussion were we compare the prevalence in Iceland, Norway, Sweden and USA is of good value and further discussion beyond the scope of the paper.
6)
As for the emerging factors of cardiovascular risk only talk about the plaque atheroma, has been studied any more? Apolipoprotein A or B, ultrasensitive PCR, homocysteine ... Response: We agree that the emerging risk factors mentioned above are of great interest but unfortunately those risk factors are not available in the REFINE-Reykjavik study.
7)
Another discussion that could be raised is what is the best definition of the carotid atheroma plaque as a risk factor, the most accurate or the easiest to obtain primary care and more useful for risk assessment? Response: What method is best to define or assess carotid atherosclerosis is a pertinent question. As discussed in the paper, attempts have been made both in Europe and in the USA to find the best method for carotid plaque identification and to standardize the methods. This will hopefully translate into better guidelines for primary care for risk assessment.
8)
I consider that as is the article is not acceptable for publication and requires major changes.
VERSION 2 -REVIEW

REVIEWER
Maria Grau IMIM -Spain
REVIEW RETURNED
28-Jan-2018
GENERAL COMMENTS I have no further comments
REVIEWER
Alba Riesgo García
Hospital Valle del Nalón, Langreo, Asturias. Spain REVIEW RETURNED 03-Feb-2018
GENERAL COMMENTS
As the authors indicate in the discussion of the study, the method of measuring the atheroma plaque between the two populations is different. Therefore, the study is not valid. For the studies to be comparable, the definition and measurement of the atheroma plaque in the carotid should be exactly the same, and they are not. I already mentioned it in the previous revision. If the objective of the study persists the comparison of the atheroma plaque in the carotid and this is done with two different methodologies, the study is not valid.
